TransMedics Group (TMDX) Earnings Date & Reports

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states... Show more

Industry: #Medical Specialties

Get AI intraday signals

A.I. Advisor

published Earnings

TMDX is expected to report earnings to rise 85.83% to 55 cents per share on July 30

TransMedics Group TMDX Stock Earnings Reports

Q2'26

Est.

$0.56

Q1'26

Missed

by $0.32

Q4'25

Beat

by $2.23

Q3'25

Beat

by $0.30

Q2'25

Beat

by $0.47

The last earnings report on May 05 showed earnings per share of 30 cents, missing the estimate of 62 cents. With 314.45K shares outstanding, the current market capitalization sits at 2.61B.

View a ticker or compare two or three

Compare

Swing Trader for Mid Caps: Comprehensive Intrinsic Sentinel, 60 min, (FA)Swing Trader for Mid Caps: Comprehensive Intrinsic Sentinel, 60 min, (FA)

Annualized Return+21%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

TMDX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement